Literature DB >> 15151508

Mutation spectrum of the glucose-6-phosphatase gene and its implication in molecular diagnosis of Korean patients with glycogen storage disease type Ia.

C-S Ki1, S-H Han, H-J Kim, S-G Lee, E-J Kim, J-W Kim, Y H Choe, J K Seo, Y J Chang, J Y Park.   

Abstract

Glycogen storage disease type Ia (GSD Ia; MIM 232200) is an autosomal recessive inherited metabolic disorder resulting from a deficiency of the microsomal glucose-6-phosphatase (G6Pase), the enzyme that catalyzes the terminal step in gluconeogenesis and glycogenolysis. Various mutations in the G6Pase gene (G6PC) have been found in patients with GSD Ia. To elucidate the spectrum of the G6PC gene mutations, 13 unrelated Korean patients with GSD Ia were analyzed. We were able to identify mutant alleles in all patients, including three known mutations (727G > T, G122D, and T255I) and two novel mutations (P178A and Y128X). The frequency of the 727G > T mutation in Korean patients with GSD Ia was 81% (21/26), which was slightly lower than that (86-92%) in Japanese but much higher than that (44.4%) in Taiwan Chinese. Except one, all patients were either homozygous (9/13) or compound heterozygous (3/13) for the 727G > T mutation; the only patient without the 727G > T mutation was a compound heterozygote for the G122D and Y128X mutations. Our findings suggest that a DNA-based test can be used as the initial diagnostic approach in Korean patients clinically suspected to have GSD Ia, thereby avoiding invasive liver biopsy.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15151508     DOI: 10.1111/j.1399-0004.2004.00260.x

Source DB:  PubMed          Journal:  Clin Genet        ISSN: 0009-9163            Impact factor:   4.438


  6 in total

Review 1.  Mutations in the glucose-6-phosphatase-alpha (G6PC) gene that cause type Ia glycogen storage disease.

Authors:  Janice Y Chou; Brian C Mansfield
Journal:  Hum Mutat       Date:  2008-07       Impact factor: 4.878

Review 2.  Glucose-6-phosphatase deficiency.

Authors:  Roseline Froissart; Monique Piraud; Alix Mollet Boudjemline; Christine Vianey-Saban; François Petit; Aurélie Hubert-Buron; Pascale Trioche Eberschweiler; Vincent Gajdos; Philippe Labrune
Journal:  Orphanet J Rare Dis       Date:  2011-05-20       Impact factor: 4.123

3.  Carrier screening by next-generation sequencing: health benefits and cost effectiveness.

Authors:  Mohammad Azimi; Kyle Schmaus; Valerie Greger; Dana Neitzel; Robert Rochelle; Tuan Dinh
Journal:  Mol Genet Genomic Med       Date:  2016-01-29       Impact factor: 2.183

4.  Molecular, Biochemical, and Clinical Characterization of Thirteen Patients with Glycogen Storage Disease 1a in Malaysia.

Authors:  Siti Aishah Abdul Wahab; Yusnita Yakob; Mohd Khairul Nizam Mohd Khalid; Noraishah Ali; Huey Yin Leong; Lock Hock Ngu
Journal:  Genet Res (Camb)       Date:  2022-09-13       Impact factor: 1.375

5.  Molecular and clinical profiling in a large cohort of Asian Indians with glycogen storage disorders.

Authors:  Tejashwini Vittal Kumar; Meenakshi Bhat; Sanjeeva Ghanti Narayanachar; Vinu Narayan; Ambika K Srikanth; Swathi Anikar; Swathi Shetty
Journal:  PLoS One       Date:  2022-07-14       Impact factor: 3.752

6.  Predominance of the c.648G > T G6PC gene mutation and late complications in Korean patients with glycogen storage disease type Ia.

Authors:  Yoo-Mi Kim; Jin-Ho Choi; Beom-Hee Lee; Gu-Hwan Kim; Kyung-Mo Kim; Han-Wook Yoo
Journal:  Orphanet J Rare Dis       Date:  2020-02-11       Impact factor: 4.123

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.